Mobile Coaching to Improve HPV Vaccine Delivery

Not Applicable

Completed

• Conditions: Vaccine Recommendation Practices; Provider Communication Practices; HPV Vaccine
• Interventions: Behavioral: QI coaching intervention

• Registration Number: NCT05105711
• Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Brief Summary

The purpose of this study is to examine the feasibility of using Checkup Coach, a mobile coaching intervention, to improve the way that primary care providers recommend HPV vaccination to adolescent patients and their parents. To conduct this feasibility study, the investigators will deliver the Checkup Coach intervention to 20 Kaiser Permanente Washington primary care providers who routinely recommend HPV vaccine to adolescent patients. The investigators will use a single-arm, pre-post design. Participating primary care providers will attend a 1-hour virtual communication workshop and then use a mobile phone app to receive additional coaching for 12 weeks. Providers will complete surveys at three time points: before the communication workshop, immediately after the workshop, and at 12-week follow-up. Surveys will assess changes in providers' self-reported HPV vaccine recommendation practices and beliefs about HPV vaccine and also acceptability of the intervention. The investigators hypothesizes that providers' HPV vaccine communication will improve between baseline and 12-week follow-up.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-21
• Study First Submitted: 2021-10-21
• Study First Submitted QC: 2021-10-21
• Study First Posted: 2021-11-03
• Primary Completion: 2022-01-14
• Study Completion: 2022-01-14
• Results First Submitted: 2022-05-31
• Status Verified: 2022-07
• Results First Submitted QC: 2022-07-20
• Last Update Submitted: 2022-07-20
• Results First Posted: 2022-07-25
• Last Update Posted: 2022-07-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

• Primary care providers who treat 11-12 year old adolescent patients in participating Kaiser Permanente Washington pediatric and family medicine practices

Exclusion Criteria

• Primary care providers who do not treat adolescent patients

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Primary care providers	QI coaching intervention	Providers who treat 11-12 year old adolescent patients in participating Kaiser Permanente Washington pediatric and family medicine practices.

Primary Outcome Measures

Name	Time	Method
Change in HPV Vaccine Recommendation Quality Score	Baseline, 12 weeks	The change in providers' mean composite score on a 5-item index of self-reported use of HPV vaccine communication practices with scores ranging from 5-25 (5 indicating the lowest quality score to 25 indicating the highest quality score).

Trial Locations

Locations (1)

Kaiser Permanente Washington Health Research Institute; 🇺🇸 Seattle, Washington, United States